Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Overdiagnosis in cancer.

Welch HG, Black WC.

J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22. Review.

2.

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.

Shiels MS, Cole SR, Kirk GD, Poole C.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22. doi: 10.1097/QAI.0b013e3181b327ca.

3.

HIV infection and the risk of cancers with and without a known infectious cause.

Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI.

AIDS. 2009 Nov 13;23(17):2337-45. doi: 10.1097/QAD.0b013e3283319184.

4.

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Welch HG, Albertsen PC.

J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9. doi: 10.1093/jnci/djp278. Epub 2009 Aug 31.

5.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

6.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

7.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H.

J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10.

8.

Pattern of cancer risk in persons with AIDS in Italy in the HAART era.

Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Tagliabue G, Zanetti R, Federico M, Limina RM, Mangone L, De Lisi V, Stracci F, Ferretti S, Piffer S, Budroni M, Donato A, Giacomin A, Bellù F, Fusco M, Madeddu A, Vitarelli S, Tessandori R, Tumino R, Suligoi B, Franceschi S; Cancer and AIDS Registries Linkage (CARL) Study.

Br J Cancer. 2009 Mar 10;100(5):840-7. doi: 10.1038/sj.bjc.6604923. Epub 2009 Feb 17.

9.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.

J Clin Oncol. 2009 Feb 20;27(6):884-90. doi: 10.1200/JCO.2008.19.6626. Epub 2008 Dec 29.

10.

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators.

Ann Intern Med. 2008 May 20;148(10):728-36.

PMID:
18490686
11.

Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.

12.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM.

Lancet. 2007 Jul 7;370(9581):59-67. Review.

PMID:
17617273
13.

Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.

Vis AN, Roemeling S, Reedijk AM, Otto SJ, Schröder FH.

Eur Urol. 2008 Jan;53(1):91-8. Epub 2007 Jun 12.

PMID:
17583416
14.
15.

Trends in cancer risk among people with AIDS in the United States 1980-2002.

Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ; HIV/AIDS Cancer Match Study.

AIDS. 2006 Aug 1;20(12):1645-54.

PMID:
16868446
16.

Cancer risk in elderly persons with HIV/AIDS.

Biggar RJ, Kirby KA, Atkinson J, McNeel TS, Engels E; AIDS Cancer Match Study Group.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):861-8.

PMID:
15213571
17.

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.

Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D.

Prev Med. 2004 Jun;38(6):732-44.

PMID:
15193893
18.

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D.

J Clin Oncol. 2003 Sep 15;21(18):3447-53.

PMID:
12972519
19.

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Sirovich BE, Schwartz LM, Woloshin S.

JAMA. 2003 Mar 19;289(11):1414-20.

PMID:
12636464
20.

Cancer incidence in New York State acquired immunodeficiency syndrome patients.

Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ.

Am J Epidemiol. 2001 Sep 15;154(6):544-56.

Items per page

Supplemental Content

Write to the Help Desk